Cargando…

Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial chemoembolization (TACE) is the first-line recommendation for intermediate-stage HCC. In real-world clinical practice, TACE also plays an im...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Bin-Yan, Jin, Zhi-Cheng, Chen, Jian-Jian, Zhu, Hai-Dong, Zhu, Xiao-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817054/
https://www.ncbi.nlm.nih.gov/pubmed/36643046
http://dx.doi.org/10.14218/JCTH.2022.00293
_version_ 1784864676824219648
author Zhong, Bin-Yan
Jin, Zhi-Cheng
Chen, Jian-Jian
Zhu, Hai-Dong
Zhu, Xiao-Li
author_facet Zhong, Bin-Yan
Jin, Zhi-Cheng
Chen, Jian-Jian
Zhu, Hai-Dong
Zhu, Xiao-Li
author_sort Zhong, Bin-Yan
collection PubMed
description Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial chemoembolization (TACE) is the first-line recommendation for intermediate-stage HCC. In real-world clinical practice, TACE also plays an important role in early- and advanced-stage HCC. This review article by the experts from Chinese Liver Cancer Clinical Study Alliance (CHANCE) summarizes the available clinical evidence pertaining to the current application of TACE in patients with early-, intermediate-, and advanced-stage HCC. In addition, combination of TACE with other treatment modalities, especially immunotherapy, is reviewed.
format Online
Article
Text
id pubmed-9817054
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher XIA & HE Publishing Inc.
record_format MEDLINE/PubMed
spelling pubmed-98170542023-01-13 Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma Zhong, Bin-Yan Jin, Zhi-Cheng Chen, Jian-Jian Zhu, Hai-Dong Zhu, Xiao-Li J Clin Transl Hepatol Review Article Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, transarterial chemoembolization (TACE) is the first-line recommendation for intermediate-stage HCC. In real-world clinical practice, TACE also plays an important role in early- and advanced-stage HCC. This review article by the experts from Chinese Liver Cancer Clinical Study Alliance (CHANCE) summarizes the available clinical evidence pertaining to the current application of TACE in patients with early-, intermediate-, and advanced-stage HCC. In addition, combination of TACE with other treatment modalities, especially immunotherapy, is reviewed. XIA & HE Publishing Inc. 2023-04-28 2022-09-06 /pmc/articles/PMC9817054/ /pubmed/36643046 http://dx.doi.org/10.14218/JCTH.2022.00293 Text en © 2023 Authors. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Zhong, Bin-Yan
Jin, Zhi-Cheng
Chen, Jian-Jian
Zhu, Hai-Dong
Zhu, Xiao-Li
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
title Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
title_full Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
title_fullStr Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
title_full_unstemmed Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
title_short Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
title_sort role of transarterial chemoembolization in the treatment of hepatocellular carcinoma
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817054/
https://www.ncbi.nlm.nih.gov/pubmed/36643046
http://dx.doi.org/10.14218/JCTH.2022.00293
work_keys_str_mv AT zhongbinyan roleoftransarterialchemoembolizationinthetreatmentofhepatocellularcarcinoma
AT jinzhicheng roleoftransarterialchemoembolizationinthetreatmentofhepatocellularcarcinoma
AT chenjianjian roleoftransarterialchemoembolizationinthetreatmentofhepatocellularcarcinoma
AT zhuhaidong roleoftransarterialchemoembolizationinthetreatmentofhepatocellularcarcinoma
AT zhuxiaoli roleoftransarterialchemoembolizationinthetreatmentofhepatocellularcarcinoma